Skip to Main Content
Contact Us
Search
Twitter
LinkedIn
Accessibity
Toggle Navigation
Search:
Search Submit
Our Company
About Us
Leadership
Board of Directors
Partnering with Spruce
Contact Us
Pipeline
Tildacerfont
Indications
Adult Classic Congenital
Adrenal Hyperplasia (CAH)
Pediatric Classic CAH
Polycystic Ovary Syndrome (PCOS)
Patients
Patient Resources
Patient Advocacy
Patient Experience
Clinical Trials
Physicians
Investors/Media
Investor/Media Home
News & Events
News Releases
Events
Presentations
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Analyst Coverage
Corporate Governance
Documents & Charters
Management Team
Board of Directors
Committee Composition
Financials & Filings
SEC Filings
Annual Reports
Quarterly Results
IR Resources
FAQs
Email Alerts
Contact IR
Careers
Contact Us
Mobile Icons
Accessibity
Our clinical trials of tildacerfont in adults with classic CAH, CAHmelia 203 and CAHmelia 204, are open for screening
|
LEARN MORE
Spruce Biosciences
Careers
Please ensure Javascript is enabled for purposes of
website accessibility